Chen Schor - 02 Nov 2022 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
President & CEO, Director
Signature
/s/ Nick Harvey, Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
02 Nov 2022
Net transactions value
-$456,718
Form type
4
Filing time
04 Nov 2022, 17:23:45 UTC
Previous filing
04 Oct 2022
Next filing
09 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale $9,000 -500 -0.36% $18.00 138,237 02 Nov 2022 See Footnote F1, F2
transaction ACET Common Stock Sale $447,718 -24,813 -18% $18.04 113,424 03 Nov 2022 See Footnote F1, F2, F3
holding ACET Common Stock 101,424 02 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $18.00 to $18.25, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission staff upon request.